News About: Pharm. Industry
Creagene to conduct phase 1 study of novel rheumatoid arthritis treatment
Creagene, a subsidiary of Choong-wae Pharm, said on June 11 that it will conduct Creavax-RA injection, a rheumatoid arthritis treatment using immunoregulation dendritic cells sooner or later after its approval from th...
Lee Kyung-ho, new head of Korea Pharmaceutical Manufacturers Association
The Korea Pharmaceutical Manufacturers Association, a pharmaceutical business lobby group, said on June 9 it appointed Lee Kyung-ho, president of Inje University as its new head at the special meeting. Lee will take o...
Quinvaxem tops Korea in drug output
Berna Biotech Korea’s Quinvaxem injection was ranked first for the consecutive two years in Korea’s drug production last year.
Quinvaxem recorded 309.7 billion won in last year’s production, followed by Dong-A’s Ba...
Korea’s pharmaceutical output totals 14.7 trillion won in 2009
Korea's total drug production by 264 manufacturers was 14.7 trillion won last year, up 6.44 percent compared with 9.1 trillion won a year earlier, according to data from the Korea Food and Drug Administration.
The ...
Yungjin to build W17.4 billion plant
Yungjin Pharm said in a regulatory filing on June 3 that it will invest 17.4 billion won to build a plant producing cephalosporin antibiotics by March next year.
“To meet the growing demand overseas, we will build ...
Ildong Chairman Lee Kum-ki to step down after 50 years
Ildong Pharm Chairman Lee Kum-ki decided to step down his chairmanship after 50 years of glorious and disgraceful history.
“I will resign as the head of the office to name my deputies independently,” Lee said.
A...
Women in 20s and 30s feel easy about use of birth control pills
Those women in their 20s and 30s are rather positive about taking birth control pills without any rejection, while those in 50s or 60s are showing concerning over their harmful effects, a local pharmaceutical company ...
Green Cross to export flu vaccines to WHO
A Korean pharmaceutical company, the Green Cross, said it will deliver Influenza A (H1N1) flu vaccine, worth $6 million, to the Pan American Health Organization (PAHO), a regional WHO body.
Last September, the PAHO...
CJ teams up with Japanese biopharmaceutical firm
CJ CheilJedang Corporation signed an agreement with RaQuaria Co. on July 7, a promising biopharmaceutical company in Japan for the development of new antiulcer drugs.
“The two companies would jointly invest a sizab...
Wyeth Korea releases Prevenar 13
Wyeth Korea said on June 7 it has launched its pneumococcal conjugate vaccine, Prevenar 13 (Pneumococcal Polysaccharide Conjugate Vaccine [13-valent, adsorbed]).
Prevenar 13 is indicated for active immunization fo...
